A new trading day began on Friday, with Intensity Therapeutics Inc (NASDAQ: INTS) stock price down -6.22% from the previous day of trading, before settling in for the closing price of $0.49. INTS’s price has ranged from $0.19 to $3.40 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -23.29%. Meanwhile, its annual earnings per share averaged 68.80%.
Intensity Therapeutics Inc (INTS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Intensity Therapeutics Inc is 10.72%, while institutional ownership is 4.54%.
Intensity Therapeutics Inc (INTS) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.22 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 68.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.43% during the next five years compared to -23.29% drop over the previous five years of trading.
Intensity Therapeutics Inc (NASDAQ: INTS) Trading Performance Indicators
Here are Intensity Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Intensity Therapeutics Inc (INTS)
Looking closely at Intensity Therapeutics Inc (NASDAQ: INTS), its last 5-days average volume was 13.47 million, which is a jump from its year-to-date volume of 10.18 million. As of the previous 9 days, the stock’s Stochastic %D was 17.92%.
During the past 100 days, Intensity Therapeutics Inc’s (INTS) raw stochastic average was set at 17.35%, which indicates a significant increase from 15.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1589 in the past 14 days, which was higher than the 0.0477 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3202, while its 200-day Moving Average is $0.9036. However, in the short run, Intensity Therapeutics Inc’s stock first resistance to watch stands at $0.4952. Second resistance stands at $0.5352. The third major resistance level sits at $0.5678. If the price goes on to break the first support level at $0.4226, it is likely to go to the next support level at $0.3900. Now, if the price goes above the second support level, the third support stands at $0.3500.
Intensity Therapeutics Inc (NASDAQ: INTS) Key Stats
With a market capitalization of 27.34 million, the company has a total of 54,999K Shares Outstanding. Currently, annual sales are 0 K while annual income is -16,270 K. The company’s previous quarter sales were 0 K while its latest quarter income was -2,540 K.
